Brief: Cabaletta Bio Announces Updated Clinical Data With Rese-Cel At February Scientific Meetings
18/02/2025 12:28
Feb 18 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO ANNOUNCES UPDATED CLINICAL DATA
DEMONSTRATING
DEEPENING CLINICAL RESPONSES ACROSS MULTIPLE INDICATIONS WITH
RESE-CEL AT FEBRUARY SCIENTIFIC MEETINGS
Source text: ID:nGNX4rpX96
Further company coverage: CABA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cabaletta Bio
See all newsCabaletta Bio Q1 net loss widens as R&D costs rise
Brief: First Patients Dosed With Cabaletta Bio’S Rese-Cel Manufactured On Cellares' Automated Cell Shuttle™ Platform
Brief: IND Amendment Clearance Obtained For Clinical Manufacturing Of Rese-Cel From Cabaletta Bio Using Cellares' Automated Platforms
Cabaletta Bio reports smaller-than-expected Q3 loss
U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity